NO.1 MEDICAL CODING TRAINING IN CALICUT
D86.0
(SARCOIDOSIS OF LUNG)
Sarcoidosis is a disease characterized by the growth of tiny collections of inflammatory cells (granulomas) in any part of your body — most commonly the lungs and lymph nodes. But it can also affect the eyes, skin, heart and other organs.
The cause of sarcoidosis is unknown, but experts think it results from the body's immune system responding to an unknown substance. Some research suggests that infectious agents, chemicals, dust and a potential abnormal reaction to the body's own proteins (self-proteins) could be responsible for the formation of granulomas in people who are genetically predisposed.
There is no cure for sarcoidosis, but most people do very well with no treatment or only modest treatment. In some cases, sarcoidosis goes away on its own. However, sarcoidosis may last for years and may cause organ damage.
SYMPTOMS
- Fatigue
- Swollen lymph nodes
- Weight loss
- Pain and swelling in joints, such as the ankles
- Persistent dry cough
- Shortness of breath
- Wheezing
- Chest pain
- A rash of red or reddish-purple bumps, usually located on the shins or ankles, which may be warm and tender to the touch
- Disfiguring sores (lesions) on the nose, cheeks and ears
- Areas of skin that are darker or lighter in color
- Growths under the skin (nodules), particularly around scars or tattoos
- Blurred vision
- Eye pain
- Burning, itching or dry eyes
- Severe redness
- Sensitivity to light
- Chest pain
- Shortness of breath (dyspnea)
- Fainting (syncope)
- Fatigue
- Irregular heartbeats (arrhythmias)
- Rapid or fluttering heart beat (palpitations)
- Swelling caused by excess fluid (edema)
- Lungs. Untreated pulmonary sarcoidosis can lead to permanent scarring in your lungs (pulmonary fibrosis), making it difficult to breathe and sometimes causing pulmonary hypertension.
- Eyes. Inflammation can affect almost any part of your eye and may cause damage to the retina, which can eventually cause blindness. Rarely, sarcoidosis also can cause cataracts and glaucoma.
- Kidneys. Sarcoidosis can affect how your body handles calcium, which can lead to kidney stones and reduce kidney function. Rarely, this can lead to kidney failure.
- Heart. Cardiac sarcoidosis results in granulomas in your heart that can disrupt heart rhythm, blood flow and normal heart function. In rare instances, this may lead to death.
- Nervous system. A small number of people with sarcoidosis develop problems related to the central nervous system when granulomas form in the brain and spinal cord. Inflammation in the facial nerves, for example, can cause facial paralysis.
- D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- D80-D89 Certain disorders involving the immune mechanism
- D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- D80-D89 Certain disorders involving the immune mechanism
- Pulmonary sarcoidosis
- Sarcoidosis with lung involvement
- Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (cecil textbook of medicine, 19th ed, p431)
- Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
ICD-10-CM D86.0 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
- 196 Interstitial lung disease with mcc
- 197 Interstitial lung disease with cc
- 198 Interstitial lung disease without cc/mcc
Convert D86.0 to ICD-9-CM
Code History- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
Comments
Post a Comment